Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/02/2022* -- Results Q3 2022 -- 2.06 --
11/02/2022* 08:30 EST Earnings Call Q3 2022 -- -- --
08/02/2022 -- Results Q2 2022 1.56 1.63 -4.12%
08/02/2022 08:30 EST Earnings Call Q2 2022 -- -- --
05/04/2022 -- Results Q1 2022 2.27 2.25 0.99%
05/04/2022 08:30 EST Earnings Call Q1 2022 -- -- --
02/02/2022 -- Results Q4 2021 1.89 1.72 9.93%
02/02/2022 08:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/02/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/02/2022
Beat/Miss Upgrade
Return Since -17.35%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
URL https://www.idexx.com
Investor Relations URL https://www.idexx.com/en/about-idexx/investors/
HQ State/Province Maine
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Growth
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Aug. 02, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-1.64%
60.82%
33.35%
18.95%
40.38%
91.43%
31.73%
-49.92%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-22.58%
-36.52%
-36.94%
95.87%
-42.67%
26.48%
1.38%
-54.99%
-48.37%
59.29%
-12.42%
222.6%
-41.84%
-24.64%
19.84%
-50.83%
-9.36%
--
6.49%
168.8%
-28.51%
48.60%
40.00%
-4.49%
-38.06%
--
--
--
-7.50%
-14.58%
29.49%
-66.43%
126.6%
As of September 27, 2022.

Profile

Edit
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
URL https://www.idexx.com
Investor Relations URL https://www.idexx.com/en/about-idexx/investors/
HQ State/Province Maine
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Growth
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Aug. 02, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
PAWZ 15.97M USD 10.59%
BARUX 236.26M USD 5.77%
BPTUX 280.58M USD 5.07%
FIW 47.16M USD 4.12%
BGRUX 208.68M USD 3.22%
IHI 163.97M USD 2.81%
CMGSX 402.24M USD 2.35%
ABPRX 235.56M USD 1.38%
FDNRX 252.02M USD 1.34%
QQQE 6.662M USD 1.02%
IWP 96.23M USD 0.88%
IMCG 8.491M USD 0.79%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter IDXX Tweets